Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1225 of 2400 entries
View as:

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT02371681 Org: User:
Start: 02/25/15 End: 11/14/17 Due: 11/14/18

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01783977 Org: User:
Start: 04/30/13 End: 10/24/18 Due: 10/24/19

G-CSF to Treat Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00025805 Org: User:
Start: 10/23/01 End: 06/13/08 Due: 06/13/09

CS DNA MVA Trial in Mampong, Ghana

Phase: N/A Priority: Normal
NCT ID: NCT00377494 Org: User:
Start: - End: 07/31/08 Due: 07/31/09

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Phase: N/A Priority: Normal
NCT ID: NCT00011037 Org: User:
Start: - End: 07/31/04 Due: 07/31/05

Bacterial Pulmonary Infection in PICU

Phase: N/A Priority: Normal
NCT ID: NCT00271531 Org: User:
Start: 04/30/06 End: 05/31/08 Due: 05/31/09

Daily Nevirapine to Prevent Mother to Infant Transmission of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00061321 Org: User:
Start: 08/31/02 End: 09/30/07 Due: 09/30/08

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Phase: N/A Priority: Normal
NCT ID: NCT03583606 Org: User:
Start: 11/12/18 End: 01/14/20 Due: 01/14/21

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

Phase: N/A Priority: Normal
NCT ID: NCT00322465 Org: User:
Start: 11/30/06 End: 04/30/09 Due: 04/30/10

Xenodiagnosis After Antibiotic Treatment for Lyme Disease

Phase: N/A Priority: Normal
NCT ID: NCT02446626 Org: User:
Start: 07/24/15 End: 05/04/22 Due: 05/04/23

Safety of the EnvPro HIV Vaccine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00076947 Org: User:
Start: 08/31/03 End: - Due: -

Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00119379 Org: User:
Start: 04/30/05 End: 10/31/08 Due: 10/31/09

The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00250198 Org: User:
Start: 11/03/05 End: 09/05/06 Due: 09/05/07

Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05398796 Org: User:
Start: 07/11/22 End: 09/17/24 Due: 09/17/25

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00013871 Org: User:
Start: - End: 11/30/04 Due: 11/30/05

Prevalence of RHD, Pyoderma and Scabies in Children in Fiji

Phase: N/A Priority: Normal
NCT ID: NCT00284843 Org: User:
Start: 01/31/06 End: 06/30/07 Due: 06/30/08

Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01856257 Org: User:
Start: 07/31/13 End: 04/30/16 Due: 04/30/17

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00001013 Org: User:
Start: - End: 09/30/91 Due: 09/30/92

Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)

Phase: N/A Priority: Normal
NCT ID: NCT00000630 Org: User:
Start: - End: 12/31/92 Due: 12/31/93

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000768 Org: User:
Start: - End: 08/31/98 Due: 08/31/99

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Phase: N/A Priority: Normal
NCT ID: NCT00000916 Org: User:
Start: - End: 08/31/04 Due: 08/31/05

Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)

Phase: N/A Priority: Normal
NCT ID: NCT00000765 Org: User:
Start: - End: 06/30/02 Due: 06/30/03

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

Phase: N/A Priority: Normal
NCT ID: NCT00000802 Org: User:
Start: - End: 07/31/97 Due: 07/31/98

A Study of the Long-Term Outcomes of HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000932 Org: User:
Start: 03/31/99 End: 09/30/06 Due: 09/30/07

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00000713 Org: User:
Start: - End: 10/31/92 Due: 10/31/93